BiotechTV - News

Pareto Securities' Healthcare Conference: Cinclus Pharma is trying to user in the next generation of acid reflux medicines with, linaprazan glurate, a potassium-competitive acid blocker (P-CAB)

Sep 16, 2025
Ask episode
Chapters
Transcript
Episode notes